( en | de | ru )

 

Disambiguierung von "Rhiem, Kerstin"

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study

, , , , , , , , , , , , , , , , , und . Breast cancer research : BCR, 14 (6): R156 (2012)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Kerstin Rhiem

Gero Rhiem

Stefan Rhiem

Stefan Rhiem

Arnd-Ragnar Rhiemeier

 

Weitere Publikationen von Autoren mit dem selben Namen

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer, , , , , , , , , und 427 andere Autor(en). Nature genetics, 45 (4): 371-84, 384e1-2 (2013)The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study, , , , , , , , , und 8 andere Autor(en). Breast cancer research : BCR, 14 (6): R156 (2012)Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making., , , , , , , , , und 3 andere Autor(en). BMC Medical Informatics Decis. Mak., 21 (1): 180 (2021)Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial., , , , , , , , und . BMC Medical Informatics Decis. Mak., 23 (1): 223 (Dezember 2023)Association of the BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast, , , , , , und . Cancer genetics and cytogenetics, 176 (1): 76–79 (2007)Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk, , , , , , , , , und 252 andere Autor(en). PLoS genetics, 9 (3): e1003212 (2013)Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium, , , , , , , , , und 13 andere Autor(en). Journal of medical genetics, 50 (6): 360–367 (2013)Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2, , , , , , , , , und 172 andere Autor(en). Breast cancer research : BCR, 13 (6): R110 (2011)Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , und 8 andere Autor(en). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (35): 5887–5892 (2009)